TRP Blur Relief Eye Drops Recalled Nationwide for Sterility Assurance Failure
TRP Blur Relief sterile eye drops (Lot #B905) are recalled due to inability to assure product sterility. Approximately 7,248 bottles were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product (sterile eye drops applied directly to the eye) where no illnesses or injuries have been reported. This matches the rubric criterion for Score 3 (High).
Plain-English summary
TRP Blur Relief sterile eye drops, 0.5 FL OZ (15mL) bottles with Lot #B905 (expiration date 07-13-2025), are being recalled. The product is manufactured by Optikem International, Inc. for TRP Company, Inc., located in Reno, Nevada.
The FDA issued this Class II recall because the manufacturer cannot assure that the product maintains sterility. Sterile eye drops require strict sterility standards due to direct application to the eye. Lack of assurance of sterility creates a risk of contamination and potential infection.
Approximately 7,248 bottles were distributed nationwide in the United States.
The recalled product
- Product
- TRP Blur Relief, Sterile Eye Drops, Homeopathic 0.5 FL OZ (15mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-002-11.
- Manufacturer
- Optikem International, Inc.
- Category
- Drug — Eye Drops
- Hazard
- sterility
- infection
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: B905
- Exp: 07-13-2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01